Literature DB >> 15110054

Mental health impact of 9/11 Pentagon attack: validation of a rapid assessment tool.

Nikki N Jordan1, Charles W Hoge, Steven K Tobler, James Wells, George J Dydek, Walter E Egerton.   

Abstract

BACKGROUND: Following the tragic events of 9/11/2001, the Pentagon Post Disaster Health Assessment (PPDHA) survey was created to identify healthcare needs and concerns among Pentagon personnel and to assure that appropriate care and information was provided. The PPDHA was fielded from October 15, 2001, to January 15, 2002. Fundamental in this assessment was the evaluation of the mental health impact as a result of the attack.
METHODS: Although a number of standardized instruments exist for mental health domains, most are lengthy and could not be used as a rapid health assessment. Instead, a short screening instrument consisting of 17 questions was developed that covered important mental health symptom domains, mental health functioning, and possible predictive risk factors. High-risk groups for post-traumatic stress disorder (PTSD), depression, panic attacks, generalized anxiety, and alcohol abuse were assessed, and validation of risk groups was assessed across functional levels.
RESULTS: Overall, 1837 (40%) respondents met the screening criteria for any of the symptom domains of interest 1 to 4 months after the attack: PTSD (7.9%), depression (17.7%), panic attacks (23.1%), generalized anxiety (26.9%), or alcohol abuse (2.5%). Mental health risk groups were highly correlated with self-reported reduced daily functioning and use of counseling services. Additionally, risk factors known to be associated with mental health problems after traumatic events were strongly predictive of the high-risk categories identified.
CONCLUSIONS: Mental health concerns were common among Pentagon employees in the 4 months after the 9/11 attack. Data from this study suggested that the short mental health screening instrument had validity and can serve as a prototype for rapid public health assessment of the mental health impact of future traumatic events.

Entities:  

Mesh:

Year:  2004        PMID: 15110054     DOI: 10.1016/j.amepre.2004.01.005

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  7 in total

1.  Workplace Stress, Organizational Factors and EAP Utilization.

Authors:  Vanessa Azzone; Bernard McCann; Elizabeth Levy Merrick; Deirdre Hiatt; Dominic Hodgkin; Constance Horgan
Journal:  J Workplace Behav Health       Date:  2009

Review 2.  Posttraumatic stress disorder following the September 11, 2001, terrorist attacks: a review of the literature among highly exposed populations.

Authors:  Yuval Neria; Laura DiGrande; Ben G Adams
Journal:  Am Psychol       Date:  2011-09

Review 3.  Post-traumatic stress disorder following disasters: a systematic review.

Authors:  Y Neria; A Nandi; S Galea
Journal:  Psychol Med       Date:  2007-09-06       Impact factor: 7.723

4.  Screening for generalized anxiety disorder symptoms in the wake of terrorist attacks: a study in primary care.

Authors:  Bita Ghafoori; Yuval Neria; Marc J Gameroff; Mark Olfson; Rafael Lantigua; Steven Shea; Myrna M Weissman
Journal:  J Trauma Stress       Date:  2009-06

5.  Dysfunction in amygdala-prefrontal plasticity and extinction-resistant avoidance: A model for anxiety disorder vulnerability.

Authors:  Jennifer E C Fragale; Veronika Khariv; Danielle M Gregor; Ian M Smith; Xilu Jiao; Stella Elkabes; Richard J Servatius; Kevin C H Pang; Kevin D Beck
Journal:  Exp Neurol       Date:  2015-11-04       Impact factor: 5.330

6.  The aftermath of terrorism: posttraumatic stress and functional impairment after the 2011 Oslo bombing.

Authors:  Øivind Solberg; Ines Blix; Trond Heir
Journal:  Front Psychol       Date:  2015-08-07

7.  Proximity to terror and post-traumatic stress: a follow-up survey of governmental employees after the 2011 Oslo bombing attack.

Authors:  Marianne B Hansen; Alexander Nissen; Trond Heir
Journal:  BMJ Open       Date:  2013-07-19       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.